Immunotherapy

The treatment of multiple myeloma has changed dramatically in recent years. Following research and therapeutic breakthroughs, it is time to debunk some of the most common myths about the disease.

New preclinical data indicate that the SIL204 treatment acts on three key mechanisms by which cancer tumors evade the immune system, strengthening the scientific basis for combination immunotherapy.